This week’s reported global health innovation funding included:

Ortet, a New York, NY-based frontier AI lab building a patient-centered foundation model for health, launched with a $500M commitment from Thoreau, the health infrastructure platform that founded the company. <source>

EliseAI, a New York, NY-based AI company automating operations for healthcare practices and housing providers, raised $350M co-led by Andreessen Horowitz and Bessemer Venture Partners, with participation from Ontario Teachers' Pension Plan, Sapphire Ventures, and Navitas Capital. <source>

Enveda Biosciences, a Boulder, CO-based company using AI to discover medicines from natural chemistry, raised $311M Series E led by Catalio Capital Management, with participation from Durable Capital Partners, ICONIQ, Lightspeed, T. Rowe Price-advised accounts, Baillie Gifford, and Premji Invest. <source>

OpenEvidence, a Miami, FL-based AI clinical search and decision support platform for physicians, raised another $250M led by Andreessen Horowitz and Byers Capital, with participation from hospital systems. <source>

Precision Neuroscience, a New York, NY-based developer of a minimally invasive brain-computer interface, raised $250M Series D co-led by Pershing Square, the Ackman Oxman Institute, and a life sciences investment fund, with participation from Duquesne Family Office, B Capital, ARK Invest, Mubadala Capital, and Hitachi Ventures. <source>

Rightway, a New York, NY-based pharmacy benefits and care navigation company, raised $155M Series E led by Francisco Partners, with participation from Thrive Capital and Khosla Ventures. <source>

Basecamp Research, a London, UK-based AI biology company building foundation models to design in vivo cell therapies, raised $140M Series C led by S32, with participation from NVIDIA, the NATO Innovation Fund, and the Rockefeller Foundation. <source>

Biolevate, a Paris, France-based agentic AI platform for life sciences scientific and regulatory workflows, raised €30M (~$34M) Series A co-led by RAISE France and Orange Ventures, with participation from MSD Global Health Innovation Fund and EQT Ventures. <source>

Tiny Health, an Austin, TX-based at-home gut and vaginal microbiome testing platform, raised $33M Series B led by B Capital, with participation from Spero Ventures, TheVentureCity, and Alumni Ventures. <source>

Ramona Optics, a Durham, NC-based developer of massively parallel computational microscopy for biomedical research, raised $25M Series A led by ARCH Venture Partners, with participation from Stealthpoint, ND Capital, Fall Line Capital, and Hamamatsu Ventures. <source>

UltraSight, a Rehovot, Israel-based AI-guided cardiac ultrasound platform, raised $24M Series C led by Alive HealthTech Growth Fund, with participation from Mayo Clinic Ventures, Connecticut Innovations, and Deep Insight. <source>

Basalt Health, a Nashville, TN-based AI platform that speeds post-acute referral intake and admissions, raised $20M Series A led by NEA, with participation from Frist Cressey Ventures and 25m Health. <source>

Inovus Medical, a St Helens, UK-based developer of surgical training simulators powered by its TOTUM software platform, raised £15M (~$20M) from the Northern Powerhouse Investment Fund, Mercia, Unorthodox Ventures, and the Liverpool City Region Life Science Innovation Zone. <source>

PNOĒ, a Malden, MA-based breath analysis company bringing lab-grade metabolic testing to gyms and clinics, raised $11M from investors including Fifty Years and Lars Rasmussen. <source>

DYAD, a London, UK-based clinical document AI company behind BetterLetter, a workflow tool for NHS GP practices, raised $10M Series A led by Sangha Capital, with participation from Bill Tai and Carbide Ventures. <source>

Redefine Surgery, an Edison, NJ-based developer of computer vision-powered surgical guidance, closed an oversubscribed pre-seed round backed largely by surgeon investors, bringing its total funding to $10M, and announced a founding partnership with Catalyst OrthoScience. <source>

Usawa, a Lisbon, Portugal-based AI-assisted digital pediatric care platform, raised $3M Seed led by Armilar, with participation from Start Ventures, Oxy Capital, and Jorge Marques. <source>

Josan-she, a Tokyo, Japan-based midwife-led pre- and postnatal care platform, raised ¥400M (~$2.6M) Series A led by WPower Fund, with participation from NEXTBLUE, FFG Venture Business Partners, and Daiwa House Ventures. <source>

Axio BioPharma, a Madison, WI-based data platform connecting biomanufacturing data across pharma sponsors and manufacturers, raised $2.4M Pre-Seed. <source>

WeGuide, a Melbourne, Australia-based digital health platform, secured A$1.9M (~$1.3M) through CUREator+, the national incubator backed by the Medical Research Future Fund, to build a platform for commercial multi-modal digital biomarkers. <source>

Cascader, a London, UK-based ophthalmic AI company spun out of Moorfields Eye Hospital and UCL, raised an undisclosed seed round led by Topcon Healthcare. <source>

MyRx, a Hyderabad, India-based doctor-network teleconsultation and e-prescription platform, raised an undisclosed seed round led by SteerX VC. <source>

Data is from StartUp Health Insights, the most comprehensive funding database for health innovation. Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox. Follow us on LinkedIn for daily updates on Health Moonshots.